BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 26559020)

  • 1. A systematic review and meta-analysis of feasibility, safety and efficacy of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) versus two-stage hepatectomy (TSH).
    Sun Z; Tang W; Sakamoto Y; Hasegawa K; Kokudo N
    Biosci Trends; 2015 Oct; 9(5):284-8. PubMed ID: 26559020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Operative Results and Oncologic Outcomes of Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) Versus Two-Stage Hepatectomy (TSH) in Patients with Unresectable Colorectal Liver Metastases: A Systematic Review and Meta-Analysis.
    Moris D; Ronnekleiv-Kelly S; Kostakis ID; Tsilimigras DI; Beal EW; Papalampros A; Dimitroulis D; Felekouras E; Pawlik TM
    World J Surg; 2018 Mar; 42(3):806-815. PubMed ID: 28798996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review and meta-analysis of portal vein ligation versus portal vein embolization for elective liver resection.
    Pandanaboyana S; Bell R; Hidalgo E; Toogood G; Prasad KR; Bartlett A; Lodge JP
    Surgery; 2015 Apr; 157(4):690-8. PubMed ID: 25704417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of different options for liver regeneration of future liver remnant in patients with liver malignancies: a systematic review and network meta-analysis.
    Yi F; Zhang W; Feng L
    World J Surg Oncol; 2022 Dec; 20(1):399. PubMed ID: 36527081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Meta-analysis of the outcomes of associating liver partition and portal vein ligation for staged hepatectomy versus portal vein embolization for the treatment of liver cancer with insufficient future liver remnant].
    Cao YL; Wang GJ; Li W
    Zhonghua Wai Ke Za Zhi; 2019 Jul; 57(7):540-548. PubMed ID: 31269618
    [No Abstract]   [Full Text] [Related]  

  • 6. Complete or partial split in associating liver partition and portal vein ligation for staged hepatectomy: A systematic review and meta-analysis.
    Huang HC; Bian J; Bai Y; Lu X; Xu YY; Sang XT; Zhao HT
    World J Gastroenterol; 2019 Oct; 25(39):6016-6024. PubMed ID: 31660037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review and meta-analysis of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) versus traditional staged hepatectomy.
    Liu Y; Yang Y; Gu S; Tang K
    Medicine (Baltimore); 2019 Apr; 98(15):e15229. PubMed ID: 30985727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): a new strategy to increase resectability in liver surgery.
    Zhang GQ; Zhang ZW; Lau WY; Chen XP
    Int J Surg; 2014; 12(5):437-41. PubMed ID: 24704086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Greater hypertrophy can be achieved with associating liver partition with portal vein ligation for staged hepatectomy compared to conventional staged hepatectomy, but with a higher price to pay?
    Chia DKA; Yeo Z; Loh SEK; Iyer SG; Bonney GK; Madhavan K; Kow AWC
    Am J Surg; 2018 Jan; 215(1):131-137. PubMed ID: 28859921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associating liver partition and portal vein ligation for staged hepatectomy versus conventional staged hepatectomy: a meta-analysis.
    Zhang Y; Zheng Y; Dong X; Sun X; Jiang X; Wang Z; Qiao H
    Minerva Med; 2018 Apr; 109(2):141-149. PubMed ID: 28398026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of associating liver partition with portal vein ligation and portal vein occlusion for two-stage hepatectomy.
    Eshmuminov D; Raptis DA; Linecker M; Wirsching A; Lesurtel M; Clavien PA
    Br J Surg; 2016 Dec; 103(13):1768-1782. PubMed ID: 27633328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histologic features after surgery associating liver partition and portal vein ligation for staged hepatectomy versus those after hepatectomy with portal vein embolization.
    Matsuo K; Murakami T; Kawaguchi D; Hiroshima Y; Koda K; Yamazaki K; Ishida Y; Tanaka K
    Surgery; 2016 May; 159(5):1289-98. PubMed ID: 26775576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associating liver partition and portal vein ligation for staged hepatectomy versus conventional two-stage hepatectomy: a systematic review and meta-analysis.
    Zhou Z; Xu M; Lin N; Pan C; Zhou B; Zhong Y; Xu R
    World J Surg Oncol; 2017 Dec; 15(1):227. PubMed ID: 29258518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No difference in mortality among ALPPS, two-staged hepatectomy, and portal vein embolization/ligation: A systematic review by updated traditional and network meta-analyses.
    Gavriilidis P; Sutcliffe RP; Roberts KJ; Pai M; Spalding D; Habib N; Jiao LR; Sodergren MH
    Hepatobiliary Pancreat Dis Int; 2020 Oct; 19(5):411-419. PubMed ID: 32753333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of split completeness on future liver remnant hypertrophy in associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) in hepatocellular carcinoma: Complete-ALPPS versus partial-ALPPS.
    Chan ACY; Chok K; Dai JWC; Lo CM
    Surgery; 2017 Feb; 161(2):357-364. PubMed ID: 27596751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technical modifications and outcomes after Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) for primary liver malignancies: A systematic review.
    Baili E; Tsilimigras DI; Moris D; Sahara K; Pawlik TM
    Surg Oncol; 2020 Jun; 33():70-80. PubMed ID: 32561102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associating liver partition and portal vein ligation for staged hepatectomy: the current role and development.
    Lau WY; Lai EC; Lau SH
    Hepatobiliary Pancreat Dis Int; 2017 Feb; 16(1):17-26. PubMed ID: 28119254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous portal and hepatic vein embolization is better than portal embolization or ALPPS for hypertrophy of future liver remnant before major hepatectomy: A systematic review and network meta-analysis.
    Gavriilidis P; Marangoni G; Ahmad J; Azoulay D
    Hepatobiliary Pancreat Dis Int; 2023 Jun; 22(3):221-227. PubMed ID: 36100542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): impact of the inter-stages course on morbi-mortality and implications for management.
    Truant S; Scatton O; Dokmak S; Regimbeau JM; Lucidi V; Laurent A; Gauzolino R; Castro Benitez C; Pequignot A; Donckier V; Lim C; Blanleuil ML; Brustia R; Le Treut YP; Soubrane O; Azoulay D; Farges O; Adam R; Pruvot FR;
    Eur J Surg Oncol; 2015 May; 41(5):674-82. PubMed ID: 25630689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the efficacy of portal vein embolization for patients with extensive liver malignancy and very low future liver remnant volume, including a comparison with the associating liver partition with portal vein ligation for staged hepatectomy approach.
    Shindoh J; Vauthey JN; Zimmitti G; Curley SA; Huang SY; Mahvash A; Gupta S; Wallace MJ; Aloia TA
    J Am Coll Surg; 2013 Jul; 217(1):126-33; discussion 133-4. PubMed ID: 23632095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.